Massivemarkets

KLRA

Kailera Therapeutics, Inc. Common Stock

Nasdaq · usd

$11.62-0.58 (-4.75%)
As of 7:30:03 PM EST on Nov 18, 2026 · 15-minute delayed

Kailera Therapeutics, Inc. Common Stock (KLRA) trades at $11.62 (-4.75%) as of 7:30:03 PM EST on Nov 18, 2026, -8.53% over the past month. Market cap is $1.53B, with 7.8 days to cover in short interest.

Stock performance

How Kailera Therapeutics, Inc. Common Stock (KLRA) stock has performed from one day to one year, with its 52-week range.

-4.40%
-$0.54 over 1D
$11.68$11.93$12.19$12.459:30 AM11:10 AM12:50 PM2:35 PM8:00 PM$11.62
1D
-3.36%
1W
-18.01%
1M
-8.53%
YTD
-54.65%
1Y
-54.65%
52-wk range
$9.76 – $28.23

Key statistics

Today's trading snapshot for KLRA: day range, open, previous close, volume and market cap.

Day range
$11.79 – $12.51
Open
$12.17
Prev close
$12.20
Volume
418.8K
Market cap
$1.53B
Shares out
129.85M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Kailera Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
1.48
P/FCF
—
ROE
-31.6%
ROA
-30.1%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 18, 2026

8-K filings

Material corporate events Kailera Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 4, 2026, Kailera Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended September 30, 2026.

  • Bylaw amendmentApr 20, 2026

    On April 20, 2026, in connection with the closing of the IPO, the amended and restated bylaws of the Company became effective. The Amended and Restated Bylaws amended and restated the Company's prior bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; and (iii) conform to the amended provisions of the Restated Certificate.

KLRA short interest

How heavily KLRA is shorted: shares short, days to cover and average daily volume.

Days to cover
7.8
Short interest
8.16M
Avg volume
1.04M

As of · reported to FINRA twice monthly.

KLRA news

The latest news and headlines about Kailera Therapeutics, Inc. Common Stock (KLRA).

Frequently asked questions

What is the Kailera Therapeutics, Inc. Common Stock (KLRA) stock price today?

Kailera Therapeutics, Inc. Common Stock (KLRA) is trading at $11.62 (-4.75% on the day) as of 7:30:03 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Kailera Therapeutics, Inc. Common Stock?

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity.

What is the short interest in KLRA?

As of Oct 30, 2026, KLRA has 8.16M shares short and 7.8 days to cover.

What exchange is KLRA listed on?

Kailera Therapeutics, Inc. Common Stock (KLRA) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of KLRA with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a KLRA analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.